Ipsen enters into an option agreement with iricor and universitÉ de montrÉal for a discovery-stage oncology program

Regulatory news: ipsen (euronext: ipn; adr: ipsey), a global specialty-driven biopharmaceutical group, iricor, a pan-canadian research commercializati

PBH Ratings Summary

PBH Quant Ranking